The New Eugenics
By Michael Dorsey,
World Watch
| 06. 30. 2002
On a not too distant horizon, advances in human biotechnology
may enable us to engineer the specific genetic makeup of our
children. Only a few months ago, the headlinemaking Italian
doctor Severino Antinori claimed to have implanted cloned embryos
in several women. We are already at the stage where we can selectively
terminate our offspring if certain genetic criteria are not
met. Soon it may be possible to discern, and ultimately select
for or against, individual traits in our children.
It is at this juncture that the promise of biotechnology runs
head-on into the history and the horrors of eugenics— the
quest for biological “improvement” through reproductive
control.
At the start of the 20th century, British scientist Francis
Galton coined the term eugenics, from the Greek eugenes, for
“well-born.” He later distinguished two major kinds
of eugenics, positive and negative. “Positive eugenics”
was preferential breeding of socalled “superior individuals”
in order to improve the genetic stock of the human race. “Negative
eugenics” meant discouraging or legally prohibiting reproduction
by individuals thought to have “inferior” genes and
was to be “achieved...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...